Latest filing published 12 Jun 2021 for Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare), €1,169.
This profile gathers the share dealings of Mary-Jane Eleanor Burkett in Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare). We count 4 filings, every one of them for a trade on 10 June 2021.
No open-market sale appears; the market trades are 4 purchases worth €5,558. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €915. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 12 June 2021: an open-market purchase of €1,169, in Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare). Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations